How are family planning methods classified?
India's national programme sorts contraceptives by what the couple wants next. MoHFW states that the methods 'can be broadly divided into two categories, spacing methods and permanent methods', with the emergency contraceptive pill as an additional method for emergencies. Spacing methods are reversible and meant for couples who still want children; permanent (terminal, limiting) methods are for couples who have completed their family.
| Group | Method | Programme brand / detail |
|---|---|---|
| Spacing — barrier | Male condom | Nirodh (free at public facilities; ASHA doorstep supply) |
| Spacing — hormonal oral | Combined oral pill | Mala-N: levonorgestrel 0.15 mg + ethinyl estradiol 30 µg; 21 hormonal + 7 iron tablets |
| Spacing — non-hormonal oral | Centchroman (ormeloxifene) | Chhaya: twice a week for 3 months, then once a week |
| Spacing — injectable | DMPA (MPA) 150 mg deep IM | Antara programme: one injection every 3 months |
| Spacing — IUCD | Cu IUCD 380A / Cu IUCD 375 | 10 years / 5 years; also post-partum (PPIUCD) and post-abortion |
| Spacing — natural | Lactational amenorrhoea method (LAM) | Valid only while all three LAM criteria are met |
| Permanent | Female sterilisation | Minilap or laparoscopic tubal occlusion |
| Permanent | Male sterilisation | No-scalpel or conventional vasectomy |
| Emergency | Levonorgestrel 1.5 mg | Ezy pill; programme advice: within 72 hours |
Textbooks also group methods by mechanism: barrier (condom, diaphragm, spermicide), hormonal (pills, injectables, implants), intrauterine devices, natural or fertility-awareness methods (LAM, calendar, withdrawal) and surgical methods. Both schemes appear in questions — read whether the stem asks about the type of method or its programme role.

What is the Pearl Index and how is it calculated?
The Pearl Index expresses contraceptive failure as the number of unintended pregnancies per 100 woman-years of exposure. Trussell describes it as 'obtained by dividing the number of unintended pregnancies by the number of years of exposure to the risk of unintended pregnancy contributed by all women in the study'. When exposure is counted in months, multiplying by 1,200 (12 months × 100 women) gives the rate per 100 woman-years.
Pearl Index = (number of accidental pregnancies × 1,200) ÷ total months of exposure
Result is failures per 100 woman-years (HWY). Some trials count 28-day cycles instead and multiply by 1,300 (13 cycles × 100).
Worked example: 100 women use a method for 12 months each (1,200 woman-months) and 3 become pregnant. Pearl Index = 3 × 1,200 ÷ 1,200 = 3 per 100 woman-years.
What is the difference between typical-use and perfect-use failure rates?
Perfect use is the failure rate when a method is used consistently and exactly as directed; typical use is what happens in real life, including missed pills, late injections and forgotten condoms. The gap is widest for methods that depend on the user at every act of intercourse or every day, and almost nil for methods that are 'fit and forget'.
| Method | Typical use | Perfect use |
|---|---|---|
| No method | 85% | 85% |
| Spermicides | 28% | 18% |
| Withdrawal | 22% | 4% |
| Male condom | 18% | 2% |
| Diaphragm | 12% | 6% |
| Combined or progestin-only pill | 9% | 0.3% |
| DMPA injectable | 6% | 0.2% |
| Copper T IUD | 0.8% | 0.6% |
| Levonorgestrel IUS | 0.2% | 0.2% |
| Female sterilisation | 0.5% | 0.5% |
| Male sterilisation | 0.15% | 0.10% |
| Implant | 0.05% | 0.05% |
Which IUCDs are used in India's programme and how do they work?
The Lippes loop entered India's programme in 1965, Copper T 200B in 1975, Cu IUCD 380A in 2002 (replacing CuT 200B) and Cu IUCD 375 in 2012, so that women could choose between a 10-year and a 5-year device.
| Feature | Cu IUCD 380A | Cu IUCD 375 |
|---|---|---|
| Shape | T-shaped | Inverted U with flexible arms (5 stubs on each side) |
| Copper | Stem and arms wound with copper; 380 mm² | Only the vertical stem wound; 375 mm² |
| Thread | White polyethylene strings | Fluorescent green nylon threads |
| Effective life | 10 years | 5 years |
- Mechanism: copper ions reduce sperm motility and function, so sperm do not reach the tube to fertilise the egg; the device also provokes a foreign-body reaction in the endometrium that hinders implantation.
- Effective immediately after insertion; usable as emergency contraception if inserted within 5 days of unprotected intercourse.
- Follow-up at 1, 3 and 6 months, because expulsion is highest in this period.
- The expiry date on the pack refers to sterility of the packet, not contraceptive life — a device inserted the day before expiry still works for its full 10 or 5 years.
| Window | Definition |
|---|---|
| Post-placental | Within 10 minutes of placental delivery after a vaginal birth |
| Intra-caesarean | After placental removal, before closure of the uterine incision |
| Within 48 hours | Any time up to 48 hours after delivery |
| Not allowed | 48 hours to 6 weeks after delivery — higher risk of infection and expulsion |
| Interval / extended post-partum | Any time after 6 weeks |


What is the Antara injectable contraceptive?
Antara is the programme name for injectable depot medroxyprogesterone acetate (DMPA, MPA), a progestogen-only injectable. One dose is a vial of 150 mg, given deep intramuscularly into the deltoid, the upper outer gluteal region or the outer thigh, every three months.
- Grace period: the repeat dose can be given up to 2 weeks early or 4 weeks late without a backup method.
- Breastfeeding: suitable from 6 weeks post-partum; it does not affect the quantity or quality of milk.
- Side effects: irregular or prolonged bleeding and amenorrhoea, weight change, headache, mood change and a decrease in bone mass.
- Return of fertility is delayed — about 7–10 months from the last injection (on average 4–6 months after the 3-month effect ends).
- A lower-dose subcutaneous MPA (104 mg/0.65 mL) is registered in India and is therapeutically equivalent to the IM form.
How is Chhaya (centchroman) taken and how does it work?
Centchroman (ormeloxifene) was developed indigenously at the Central Drug Research Institute (CDRI), Lucknow, and was added to the programme as Chhaya in April 2016. It is a non-steroidal, non-hormonal pill that acts as a selective oestrogen receptor modulator (SERM) — weakly oestrogenic in some tissues such as bone and strongly anti-oestrogenic in the uterus and breast.
- First 3 months: one 30 mg pill twice a week — the first on day 1 of the period and the second 3 days later, on the same two weekdays thereafter.
- From the 4th month: once a week, on the first pill day, regardless of the menstrual cycle.
- Missed pill: take it as soon as remembered; if more than 7 days late, restart as a new user (twice weekly for 3 months).
It does not stop ovulation; it acts mainly by making the endometrium unreceptive and disturbing the timing of embryo transport, so implantation fails. It is safe during breastfeeding. Its main effect on the cycle is prolongation of the cycle with lighter periods, which MoHFW describes as helpful for anaemic women; if a period is delayed by more than 15 days, pregnancy must be excluded.
What are the options for emergency contraception?
Emergency contraception is used after unprotected intercourse, contraceptive failure (such as a burst condom or missed pills) or coerced sex. It is not an abortifacient: WHO states that emergency pills 'prevent pregnancy by preventing or delaying ovulation and they do not induce an abortion'.
| Option | Dose / method | Time window | Key point |
|---|---|---|---|
| Levonorgestrel pill | 1.5 mg single dose (programme: Ezy pill) | Programme: within 72 hours; WHO: up to 120 hours | Most effective the sooner it is taken |
| Ulipristal acetate | 30 mg single dose | Up to 120 hours | More effective than other pills between 72 and 120 hours |
| Yuzpe regimen | 100 µg ethinyl estradiol + 0.5 mg levonorgestrel, repeated after 12 hours | Up to 120 hours | Combined pills used as emergency contraception |
| Copper IUCD | Insertion | Within 5 days (120 hours) | Most effective option (>99%); continues as regular contraception |
What are the WHO medical eligibility criteria categories?
The WHO Medical Eligibility Criteria (MEC), adapted by MoHFW, grade each condition for each method into four categories.
| Category | Meaning | Action |
|---|---|---|
| 1 | No restriction for use | Use the method |
| 2 | Advantages generally outweigh risks | Generally use |
| 3 | Risks usually outweigh advantages | Generally do not use |
| 4 | Unacceptable health risk | Do not use |
| Combined oral pill — category 4 | Copper IUCD — category 4 |
|---|---|
| Breastfeeding, less than 6 weeks post-partum | Known or suspected pregnancy |
| BP ≥ 160 systolic or ≥ 100 diastolic; vascular disease | Unexplained vaginal bleeding |
| History of or acute DVT/PE | Current PID, gonorrhoea or chlamydia; purulent discharge |
| Ischaemic heart disease or stroke; complicated valvular disease | Distorted uterine cavity |
| Migraine with aura (any age) | Malignant trophoblastic disease |
| Current breast cancer | Known pelvic tuberculosis |
| Acute hepatitis; severe cirrhosis | Cervical or endometrial cancer |
When can lactational amenorrhoea be relied on?
LAM is a temporary natural method. MoHFW lists three criteria that must all be met: the baby is less than 6 months old, menses have not returned, and the baby is fully or nearly fully breastfed, often, day and night.
As soon as any one criterion fails — periods return, breastfeeds are reduced or bottle feeds start, or the baby reaches 6 months — another method must be started. Other natural methods (calendar, withdrawal) have high typical-use failure: withdrawal fails in about 22% of couples in the first year.
What are an eligible couple and the couple protection rate?
An eligible couple is a currently married couple in which the wife is in the reproductive age group — the textbook definition used in Indian exams (Park) is a wife aged 15–45 years, while NFHS surveys use 15–49 years. Eligible couples are the target group that ASHAs and ANMs counsel about family planning methods in the community.
The couple protection rate (CPR) expresses how many eligible couples are protected by an approved contraceptive method, as a percentage. It is the proxy measure used to judge contraceptive use among eligible couples, and it rises as more couples adopt spacing or permanent methods.